Page 1

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement , make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement . 中國 人壽保險 股份有限公司 CHINA LIFE INSURANCE COMPANY LIMITED ( A joint stock limited company incorporated in the People's Republic of China with limited liability ) ( Stock Code : 2628 ) ANNOUNCEMENT OF UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2021 CHAIRMAN'S STATEMENT 2021 marks the beginning of the 14th Five - Year Plan period . China Life fully implemented the national decision and deployment , and upheld the guideline of making progress while maintaining stability , aiming for continuous high - quality development . At a new development stage , we implemented the new development concept , served the new development pattern , and achieved a stable business development . I , on behalf of the Company's board of directors ( the “ Board ” ) , hereby report to shareholders and the public on the Company's operating results for the first half of 2021 . During the Reporting Period , the complicated and ever - changing external environment , coupled with the restrained demands for insurance affected by the COVID - 19 pandemic , brought multiple challenges to the recovery of the life insurance industry . China Life took proactive measures in response to these changes and forged ahead under pressure , further solidifying its comprehensive strengths and market leading advantages , and demonstrating its strong development resilience . During the Reporting Period , the Company's gross written premiums amounted to RMB442,299 million , an increase of 3.5 % year on year , achieving a continuous growth on the high base for two consecutive years . Total assets were RMB4,652,793 million , increasing by 9.4 % from the end of 2020. The embedded value of the Company reached RMB1,142,811 million , leading the industry . During the Reporting Period , net profit attributable to equity holders of the Company was RMB40,975 million , an increase of 34.2 % year on year . As at the end of the Reporting Period , the core solvency ratio and the comprehensive solvency ratio were 259.03 % and 267.69 % , respectively .